(Q46139302)

19 December 2017

title

A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain). (English)

1 reference

19 December 2017

1 reference

Mark A Jacobson

1

1 reference

19 December 2017

Stuart P Adler

2

1 reference

19 December 2017

Elizabeth Sinclair

3

1 reference

19 December 2017

Douglas Black

4

1 reference

19 December 2017

Anna Smith

5

1 reference

19 December 2017

Alice Chu

6

1 reference

19 December 2017

Ron B Moss

7

1 reference

19 December 2017

Mary K Wloch

8

1 reference

19 December 2017

language of work or name

English

0 references

publication date

23 January 2009

1 reference

19 December 2017

published in

Vaccine

1 reference

19 December 2017

volume

27

1 reference

19 December 2017

issue

10

1 reference

19 December 2017

page(s)

1540-1548

1 reference

19 December 2017

Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.006

10.1016/J.VACCINE.2009.01.006

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017